Pancreatic Cancer Research

ResearcherCedars-Sinai Medical CenterActive in the last 2 years

Qiang Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9409-0251; OpenAlex author ID A5100686126. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
26
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 7

  1. Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells. Co-author DOI 10.1016/j.freeradbiomed.2024.01.003↗
  2. Epithelial cell transforming 2 is regulated by Yes-associated protein 1 and mediates pancreatic cancer progression and metastasis. Last author DOI 10.1152/ajpgi.00185.2020↗
  3. MSP-RON Signaling Is Activated in the Transition From Pancreatic Intraepithelial Neoplasia (PanIN) to Pancreatic Ductal Adenocarcinoma (PDAC). Last author DOI 10.3389/fphys.2019.00147↗
  4. An Inhibitor of GSK3B and HDACs Kills Pancreatic Cancer Cells and Slows Pancreatic Tumor Growth and Metastasis in Mice. Co-author DOI 10.1053/j.gastro.2018.08.028↗
  5. Cadherin-11 Is a Cell Surface Marker Up-Regulated in Activated Pancreatic Stellate Cells and Is Involved in Pancreatic Cancer Cell Migration. Co-author DOI 10.1016/j.ajpath.2016.09.012↗
  6. Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitis. Last author DOI 10.1038/srep16759↗
  7. Establishment of an orthotopic pancreatic cancer mouse model: cells suspended and injected in Matrigel. Co-author DOI 10.3748/wjg.v20.i28.9476↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Stephen Jacob Pandol · 6 shared papers, 2015–2024 · strength 0.61
  2. Mouad Edderkaoui · 4 shared papers, 2017–2024 · strength 0.42
  3. Susan Morvaridi · 3 shared papers, 2015–2019 · strength 0.21
  4. Ce Li · 2 shared papers, 2019–2021 · strength 0.21
  5. Nicholas N. Nissen · 2 shared papers, 2019–2021 · strength 0.21
  6. Tao Liu · 1 shared paper, 2024 · strength 0.21
  7. Omer Hany Miligy Elmadbouh · 1 shared paper, 2024 · strength 0.21
  8. Wei Jie Zhou · 1 shared paper, 2024 · strength 0.21
  9. Raul A. Urrutia · 1 shared paper, 2024 · strength 0.21
  10. Arsen Osipov · 1 shared paper, 2024 · strength 0.21
  11. Neil A. Bhowmick · 1 shared paper, 2018 · strength 0.07
  12. Aida Habtezion · 1 shared paper, 2018 · strength 0.07
  13. László G. Boros · 1 shared paper, 2018 · strength 0.07
  14. Jian Tajbakhsh · 1 shared paper, 2018 · strength 0.07
  15. Richard Tuli · 1 shared paper, 2018 · strength 0.07
  16. Ramachandran Murali · 1 shared paper, 2018 · strength 0.07
  17. Deepti Dhall · 1 shared paper, 2015 · strength 0.06
  18. Chiara Birtolo · 1 shared paper, 2017 · strength 0.06
  19. Hung Pham · 1 shared paper, 2017 · strength 0.06
  20. Brent K. Larson · 1 shared paper, 2017 · strength 0.06
  21. Vay Liang W. Go · 1 shared paper, 2017 · strength 0.06
  22. Chong-Lek Lee · 1 shared paper, 2014 · strength 0.05
  23. Feng Yang · 1 shared paper, 2014 · strength 0.05
  24. Chen Jin · 1 shared paper, 2014 · strength 0.05
  25. Yongjian Jiang · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.